75 related articles for article (PubMed ID: 12867355)
1. Special intervention reduces CVD mortality for adherent participants in the multiple risk factor intervention trial.
Gump BB; Matthews KA
Ann Behav Med; 2003 Aug; 26(1):61-8. PubMed ID: 12867355
[TBL] [Abstract][Full Text] [Related]
2. Hostile behaviors predict cardiovascular mortality among men enrolled in the Multiple Risk Factor Intervention Trial.
Matthews KA; Gump BB; Harris KF; Haney TL; Barefoot JC
Circulation; 2004 Jan; 109(1):66-70. PubMed ID: 14662707
[TBL] [Abstract][Full Text] [Related]
3. Risk factor changes after cessation of intervention in the Multiple Risk Factor Intervention Trial. The MRFIT Research Group.
Cutler JA; Grandits GA; Grimm RH; Thomas HE; Billings JH; Wright NH
Prev Med; 1991 Mar; 20(2):183-96. PubMed ID: 2057467
[TBL] [Abstract][Full Text] [Related]
4. Mortality after 10 1/2 years for hypertensive participants in the Multiple Risk Factor Intervention Trial.
Circulation; 1990 Nov; 82(5):1616-28. PubMed ID: 2225366
[TBL] [Abstract][Full Text] [Related]
5. Depressive symptoms and mortality in men: results from the Multiple Risk Factor Intervention Trial.
Gump BB; Matthews KA; Eberly LE; Chang YF;
Stroke; 2005 Jan; 36(1):98-102. PubMed ID: 15569872
[TBL] [Abstract][Full Text] [Related]
6. Lung cancer mortality after 16 years in MRFIT participants in intervention and usual-care groups. Multiple Risk Factor Intervention Trial.
Shaten BJ; Kuller LH; Kjelsberg MO; Stamler J; Ockene JK; Cutler JA; Cohen JD
Ann Epidemiol; 1997 Feb; 7(2):125-36. PubMed ID: 9099400
[TBL] [Abstract][Full Text] [Related]
7. Multiple risk factor intervention trial revisited: a new perspective based on nonfatal and fatal composite endpoints, coronary and cardiovascular, during the trial.
Stamler J; Neaton JD; Cohen JD; Cutler J; Eberly L; Grandits G; Kuller LH; Ockene J; Prineas R;
J Am Heart Assoc; 2012 Oct; 1(5):e003640. PubMed ID: 23316301
[TBL] [Abstract][Full Text] [Related]
8. Mortality after 16 years for participants randomized to the Multiple Risk Factor Intervention Trial.
Circulation; 1996 Sep; 94(5):946-51. PubMed ID: 8790030
[TBL] [Abstract][Full Text] [Related]
9. Baseline rest electrocardiographic abnormalities, antihypertensive treatment, and mortality in the Multiple Risk Factor Intervention Trial. Multiple Risk Factor Intervention Trial Research Group.
Am J Cardiol; 1985 Jan; 55(1):1-15. PubMed ID: 3880997
[TBL] [Abstract][Full Text] [Related]
10. Hypertension management in the Multiple Risk Factor Intervention Trial (MRFIT). Six-year intervention results for men in special intervention and usual care groups.
Grimm RH; Cohen JD; Smith WM; Falvo-Gerard L; Neaton JD
Arch Intern Med; 1985 Jul; 145(7):1191-9. PubMed ID: 3893343
[TBL] [Abstract][Full Text] [Related]
11. Mortality in participants and non-participants of a multifactorial prevention study of cardiovascular diseases: a 28 year follow up of the Helsinki Businessmen Study.
Strandberg TE; Salomaa VV; Vanhanen HT; Naukkarinen VA; Sarna SJ; Miettinen TA
Br Heart J; 1995 Oct; 74(4):449-54. PubMed ID: 7488463
[TBL] [Abstract][Full Text] [Related]
12. Global cardiovascular mortality risk in the adult Polish population: prospective assessment of the cohorts studied in multicentre national WOBASZ and WOBASZ Senior studies.
Piotrowski W; Waśkiewicz A; Cicha-Mikołajczyk A
Kardiol Pol; 2016; 74(3):262-73. PubMed ID: 26365939
[TBL] [Abstract][Full Text] [Related]
13. Electrocardiographic abnormalities and coronary heart disease mortality among hypertensive men in the Multiple Risk Factor Intervention Trial.
Rautaharju PM; Neaton JD
Clin Invest Med; 1987 Nov; 10(6):606-15. PubMed ID: 3326700
[TBL] [Abstract][Full Text] [Related]
14. Brief description of the Multiple Risk Factor Intervention Trial.
Kjelsberg MO; Cutler JA; Dolecek TA
Am J Clin Nutr; 1997 Jan; 65(1 Suppl):191S-195S. PubMed ID: 8988937
[TBL] [Abstract][Full Text] [Related]
15. Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: a randomized controlled trial.
Lee JK; Grace KA; Taylor AJ
JAMA; 2006 Dec; 296(21):2563-71. PubMed ID: 17101639
[TBL] [Abstract][Full Text] [Related]
16. A long-term nutrition intervention experience: lipid responses and dietary adherence patterns in the Multiple Risk Factor Intervention Trial.
Dolecek TA; Milas NC; Van Horn LV; Farrand ME; Gorder DD; Duchene AG; Dyer JR; Stone PA; Randall BL
J Am Diet Assoc; 1986 Jun; 86(6):752-8. PubMed ID: 3519737
[TBL] [Abstract][Full Text] [Related]
17. Are vacations good for your health? The 9-year mortality experience after the multiple risk factor intervention trial.
Gump BB; Matthews KA
Psychosom Med; 2000; 62(5):608-12. PubMed ID: 11020089
[TBL] [Abstract][Full Text] [Related]
18. Exercise electrocardiogram and coronary heart disease mortality in the Multiple Risk Factor Intervention Trial. Multiple Risk Factor Intervention Trial Research Group.
Am J Cardiol; 1985 Jan; 55(1):16-24. PubMed ID: 2857061
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of a nurse-led email reminder program for cardiovascular prevention risk reduction in hypertensive patients: a randomized controlled trial.
Cicolini G; Simonetti V; Comparcini D; Celiberti I; Di Nicola M; Capasso LM; Flacco ME; Bucci M; Mezzetti A; Manzoli L
Int J Nurs Stud; 2014 Jun; 51(6):833-43. PubMed ID: 24225325
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
